We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
127 hedge funds and large institutions have $1.06B invested in Alder Biopharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 55 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
129% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 24
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
3% more funds holding
Funds holding: 123 → 127 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less call options, than puts
Call options by funds: $1.15M | Put options by funds: $1.16M
12% less capital invested
Capital invested by funds: $1.21B → $1.06B (-$147M)
Holders
127
Holders Change
+4
Holders Change %
+3.25%
% of All Funds
2.76%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
20
Increased
55
Reduced
24
Closed
13
Calls
$1.15M
Puts
$1.16M
Net Calls
-$10K
Net Calls Change
-$387K
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$34.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$20M |
| 3 |
BlackRock
New York
|
+$14.2M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$8.99M |
| 5 |
Goldman Sachs
New York
|
+$6.78M |
